Kevin John Smith
11Patents
7h-index
25Co-inventors
66Inventor score
Filing activity: May 10, 1994 → Apr 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5879705A | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions | Human Necessities | 247 | Expired |
| US6254887A | Controlled release tramadol | Human Necessities | 166 | Expired |
| US5591452A | Controlled release formulation | Human Necessities | 151 | Expired |
| US6326027A | Controlled release formulation | Human Necessities | 151 | Expired |
| US6143328A | Sustained release compositions and a method of preparing pharmaceutical compositions | Human Necessities | 96 | Expired |
| US7074430B2 | Controlled release tramadol tramadol formulation | Human Necessities | 69 | Expired |
| US9549903B2 | Transdermal delivery system comprising buprenorphine | Human Necessities | 10 | Active |
| US11020343B2 | Intranasal pharmaceutical dosage forms comprising naloxone | Human Necessities | 4 | Active |
| US9782359B2 | Opioid composition for treating skin lesions | Human Necessities | 0 | Active |
| US11806428B2 | Intranasal pharmaceutical dosage forms comprising naloxone | Human Necessities | 0 | Active |
| US10898479B2 | Dihydroetorphine for the provision of pain relief and anaesthesia | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.